Impact BioMedical Inc.
IBO
$0.58
$0.00-0.46%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -806.10% | -438.96% | -469.83% | 118.03% | 43.97% |
| Total Depreciation and Amortization | 40.00% | 0.00% | 16.67% | 100.72% | 25.00% |
| Total Amortization of Deferred Charges | 0.90% | 0.18% | -0.18% | -42.81% | 0.09% |
| Total Other Non-Cash Items | 7,635.54% | 6,530.48% | 29,380.28% | -340.42% | -87.00% |
| Change in Net Operating Assets | -174.48% | -167.98% | -239.45% | -10.20% | 319.30% |
| Cash from Operations | -98.73% | -55.58% | -19.54% | 7.05% | 32.31% |
| Capital Expenditure | -- | -- | -- | 100.00% | 99.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 50.00% | -33.33% | 0.00% | 0.00% |
| Cash from Investing | 100.00% | 127.27% | 113.33% | 101.03% | 100.34% |
| Total Debt Issued | -58.81% | -48.73% | -41.43% | -58.29% | -35.97% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 130.42% | 111.11% | 88.62% | 59.17% | -35.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62,300.00% | 131,500.00% | 199,900.00% | 2,367.00% | 99.22% |